Results 141 to 150 of about 252,954 (227)
Virus MERS-Coronavirus (CoV): preguntes més freqüents [PDF]
MERS-CoV; Coronavirus; Preguntes freqüentsMERS-CoV; Coronavirus; Preguntas frecuentesMERS-CoV; Coronavirus; Frequently asked questionsAquest informe recull informació de preguntes i respostes sobre el virus MERS-Coronavirus (CoV)
Torner-Gràcia, Núria
core
Treating MERS-CoV during an outbreak [PDF]
Coleman, Christopher M +1 more
openaire +2 more sources
MERS-CoV p4a increases mengovirus fitness.
(A) Immune fluorescence images of HeLa-wt and HeLa-PKRKO cells infected with EMCV-L-Zn (MOI = 10). Cells were fixed at 6h post infection and SG formation was visualized using antibodies directed against G3BP1 (shown in green) and eIF3 (shown in red ...
Isabel Sola (218107) +10 more
core +1 more source
BackgroundIn April 2012, the Jordan Ministry of Health investigated an outbreak of lower respiratory illnesses at a hospital in Jordan; 2 fatal cases were retrospectively confirmed by real-time reverse transcription polymerase chain reaction (rRT-PCR) to
core
DPP4 in MERS-CoV Transmission and Pathogenesis [PDF]
MERS-CoV is a virus that commonly infects dromedary camels in the Arabian Peninsula and Africa. This virus spreads effectively in this species and merely causes mild upper respiratory tract infection.
Widagdo, W. (Widagdo)
core
Identification of MERS-CoV in dromedary camels [PDF]
Ferguson, Neil M, Van Kerkhove, Maria D
openaire +2 more sources
The present invention relates to a mutant receptor-binding domain (MERS-mRBD) of MERS-CoV (middle east respiratory syndrome coronavirus) or a fragment thereof and a mutant spike protein (MERS-mSpike) of MERS-CoV or a fragment thereof.
Olsson, S. +3 more
core
Decoding antibody response to MERS-CoV in wild dromedary camels. [PDF]
Idoudi F +18 more
europepmc +1 more source

